Nichi-Iko Of Japan Invests ¥7.3 Billion To Build New Production Facility
This article was originally published in PharmAsia News
Executive Summary
Toyama-based generic drug maker Nichi-Iko Pharmaceutical announced it will build a new production facility in Katsukawa, Toyama prefecture. Chiyoda TechnoAce, a subsidiary of Yokohama-based Chiyoda Corp has been awarded the ¥7.3 billion construction contract. Construction starts this September and will be completed by October 2009. Actual production is expected to start in December 2009. The Japanese generics market has been growing and generics makers are speeding up facility investment and the integration of production and research facilities to boost efficiency. (Click here for more - Japanese language